Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies Recruiting

2023-504931-42-00 Chronic lymphocytic leukemia/Small lymphocytic lymphoma 2021-04-06
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 2021-04-01
AGADIR : Atezolizumab combined with EIK10001 (BDB001) and Immunogenic Radiotherapy in Patients with Advanced Solid Tumors Recruiting

2023-509492-16-00 Adult participants with metastatic (advanced) solid tum 2021-03-30
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negativ… Recruiting

2024-515063-66-00 Early stage classical Hodgkin Lymphoma (cHL) without bu 2021-03-30
Vaccination with Autologous Dendritic cells loaded with Autologous Tumour homogenate in Glioblastoma: a phase II Study Recruiting

2024-512493-98-00 Glioblastoma 2021-03-25
RETINO 2018: conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome Recruiting

2024-514025-30-00 Ocular conservative treatment for retinoblastoma 2021-03-25
Open-label Phase 2 of tabelecleucel in Subjects with Epstein Barr Virus associated Diseases (EBVision) Recruiting

2024-516623-14-00 EBV+ primary imunodeficiency lymphoproliferative diseas 2021-03-17
Sequential neoadjuvant ifosfamide and doxorubicin in localized high-grade soft tissue sarcoma of extremities and trunk wall Recruiting

2023-510185-27-00 Patients with high-grade soft tissue sarcoma of the ext 2021-03-01
FIGO 2018 stage IB2 (>2 cm - ≤4 cm ) Cervical Cancer Treated with Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery (CoNteSSa)… Recruiting

2023-507230-24-00 Cervical cancer 2021-02-17
“A phase II, single arm study investigating neoadjuvant plus adjuvant treatment with Cemiplimab in surgically resectable, high risk stage II… Recruiting

2024-515204-39-00 surgically resectable, high risk stage III/IV (M0) Cuta 2021-02-10
Induction and maintenance treatment with PARP inhibitor and immunotherapy in HPV-negative Head and Neck Squamous Cell Carcinoma (HNSCC). PRI… Recruiting

2024-516798-54-00 HPV-negative Head and Neck Squamous Cell Carcinoma (HNS 2021-02-08
Efficacy of bone marrow-derived stem cells in treatment of knee cartilage defects. Recruiting

2023-503486-32-00 Knee Cartilage Defect 2021-02-04
INTOReTAK - Multicentre, randomized, prospective trial evaluating the efficacy and safety of Infliximab to tocilizumab in refractory or rela… Recruiting

2024-512229-10-00 Takayasu arteritis 2021-02-04
A phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric an… Recruiting

2024-510720-38-00 Dementia with Lewy Bodies 2021-01-12
A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Su… Recruiting

2024-520058-39-00 Plaque Psoriasis 2020-12-28
Study evaluating near-infrared imaging coupled with indocyanine green for intraoperative monitoring of resection margins in ENT surgery Recruiting

2022-502737-26-00 epidermoid carcinoma 2020-12-15
IMMUWIN - A Phase II study of immunotherapy with durvalumab (MEDI4736) and tremelimumab in combination with Y-90 SIRT for intermediate stage… Recruiting

2024-513950-32-00 Intermediate stage hepatocellular carcinoma (HCC) 2020-12-15
Beta-blockade in cardiac arrest Recruiting

2024-518949-14-00 cardiac arrest, ventricular fibrillation 2020-11-30
Phase II study of adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the prevention of peritoneal metastases after curati… Recruiting

2024-513376-17-00 colorectal cancer 2020-11-24
GROINSS-V III Recruiting

2023-508722-99-00 Vulvar cancer 2020-11-19
“A phase II randomized non-comparative study, with NEOadjuvant plus adjuvant Therapy with combination or sequence of vemurafenib, cobImetini… Recruiting

2024-516659-41-00 high-risk, surgically resectable BRAF mutated and wild- 2020-10-12
Evaluation of the use of contrast agent in mammography to improve the specificity of breast cancer diagnosis Recruiting

2024-517486-16-00 Patients with breast lesions undergoing further examina 2020-09-30
SUBCUTANEOUS INJECTIONS OF AUTOLOGOUS CULTURED ADIPOSE-DERIVED STROMA/ STEM CELLS TO HEAL REFRACTORY ISCHEMIC DIGITAL ULCERS IN PATIENTS WIT… Recruiting

2023-508432-53-00 Systemic sclerosis 2020-09-22
PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF EARLY OXYBUTININ TREATMENT FOR BOYS WITH POSTERIOR URETHRAL VALVES - PRETIPUV - Recruiting

2024-515844-22-00 urethral posterior valve 2020-09-10